Skip to main content

Shattuck Labs, Inc.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

STTK$4.99+8.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, on this 27th day of March 2025

Shattuck Labs, Inc.
Date: March 27, 2025By:/s/ Dr. Taylor Schreiber
Dr. Taylor Schreiber
Chief Executive Officer
(principal executive officer)
Date: March 27, 2025By:/s/ Andrew R. Neill
Andrew R. Neill
Chief Financial Officer
(principal financial and accounting officer)

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Dr. Taylor Schreiber, Andrew R. Neill and Stephen Stout, and each of them, as true and lawful attorneys-in-fact and agents, with full powers of substitution and resubstitution, for them and in their name, place and stead, in any and all capacities, to sign in any and all capacities (including, without limitation, the capacities listed below), this Annual Report on Form 10-K, any and all amendments thereto, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and anything necessary to be done to enable the registrant to comply with the provisions of the Securities Exchange Act and all the requirements of the Securities and Exchange Commission, as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his or her substitute, or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons in the capacities and on the dates set forth opposite their names.

SignatureTitleDate
/s/ Dr. Taylor SchreiberChief Executive Officer and DirectorMarch 27, 2025
Dr. Taylor Schreiber(principal executive officer)
/s/ Andrew R. NeillChief Financial OfficerMarch 27, 2025
Andrew R. Neill(principal financial and accounting officer)
/s/ Dr. George GolumbeskiChairman of the BoardMarch 27, 2025
Dr. George Golumbeski
/s/ Helen M. BoudreauDirectorMarch 27, 2025
Helen M. Boudreau
/s/ Dr. Neil GibsonDirectorMarch 27, 2025
Dr. Neil Gibson
/s/ Dr. Carrie BrownsteinDirectorMarch 27, 2025
Dr. Carrie Brownstein
/s/ Michael LeeDirectorMarch 27, 2025
Michael Lee
/s/ Tyler BrousDirectorMarch 27, 2025
Tyler Brous
/s/ Dr. Kate SasserDirectorMarch 27, 2025
Dr. Kate Sasser
/s/ Dr. Clay SiegallDirectorMarch 27, 2025
Dr. Clay Siegall
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.